• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Energy Market
    Energy News
    Energy Stocks
    • Energy Market
    • Energy News
    • Energy Stocks
    market news

    Laramide Resources Updates on Church Rock and Crownpoint Projects

    Charlotte McLeod
    Jan. 12, 2018 01:29PM PST
    Energy Investing

    Laramide Resources Ltd. (TSX:LAM,ASX:LAM) announced that it has made its anniversary payment to Westwater Resources Inc. (NASDAQ:WWR) for the acquisition of the Church Rock and Crownpoint uranium projects.

    Laramide Resources Ltd. (TSX:LAM,ASX:LAM) announced that it has made its anniversary payment to Westwater Resources Inc. (NASDAQ:WWR) for the acquisition of the Church Rock and Crownpoint uranium projects.
    The company also provided an updated on activities at both projects.
    As quoted in the press release:

    The US$1.5 million payment (the “Payment”) consisted of a US$750,000 cash payment and the issuance of 1,982,483 common shares based on the volume weighted average price (“VWAP”) of Laramide’s common shares for the 20 days before the anniversary date of the Acquisition, which was C$0.4724 per share. The common shares issued pursuant to the Payment are subject to a statutory four-month hold period expiring on May 13, 2018. The Payment reduced the outstanding promissory note (the “Note”) to the principal amount of US$3.5 million, with two remaining payments, due in January 2019 (US$1.5 million), and January 2020(US$2.0 million). Pursuant to the Note, Laramide has the right to elect to repay up to 50% of the outstanding principal under the Note in the form of common shares of Laramide issued at a price equal to the 20-day VWAP at the time of such payment.
    Pursuant to the terms of the Acquisition, Westwater was granted a one-year option to acquire Laramide’s La Saluranium project in Utah and La Jara Mesa in New Mexico for US$3 million and US$5 million, respectively (the “Option”). Laramide received notification by Westwater that they have elected not to exercise and the Option has expired.

    Click here to read the full Laramide Resources Ltd. (TSX:LAM,ASX:LAM) press release.

    market newstsx:lam
    The Conversation (0)

    Go Deeper

    AI Powered
    Uranium Outlook

    Uranium Outlook

    Purepoint Uranium (TSXV:PTU, OTCQB:PTUUF)

    Purepoint Uranium

    Latest News

    Funding to Accelerate H2 and CO2 Commercialisation

    Acquires Extensive Uranium and Rare Earth Portfolio

    Strong Start to Maiden Drill Program at Oasis

    Basin Energy Ltd Investor Webinar and Presentation

    Basin Energy Ltd Acquires Extensive Uranium and Rare Earth Portfolio

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×